Clinical Trial

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a Phase 1, randomized, blinded, placebo controlled, single ascending dose (SAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-16.
Trial Details
NCT Number NCT07239947
Lead Sponsor Bambusa Therapeutics
Conditions Atopic Dermatitis
Enrollment 99 participants
Start Date 2025-08-09
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22